Citadel Advisors’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.19M | Sell |
|
|||||
|
2025
Q2 | $7.97M | Sell |
|
|||||
|
2025
Q1 | $9.76M | Buy |
|
|||||
|
2024
Q4 | $7.45M | Buy |
|
|||||
|
2024
Q3 | $6.15M | Buy |
|
|||||
|
2024
Q2 | $2.56M | Buy |
|
|||||
|
2024
Q1 | $3.78M | Sell |
|
|||||
|
2023
Q4 | $33M | Buy |
|
|||||
|
2023
Q3 | $22.5M | Buy |
|
|||||
|
2023
Q2 | $17.5M | Buy |
|
|||||
|
2023
Q1 | $6.72M | Buy |
|
|||||
|
2022
Q4 | $2.1M | Sell |
|
|||||
|
2022
Q3 | $22.7M | Buy |
|
|||||
|
2022
Q2 | $14.5M | Buy |
|
|||||
|
2022
Q1 | $6.45M | Buy |
|